Lipella Pharmaceuticals director David Battleman resigns effective June 17, 2023

LIPELLA PHARMACEUTICALS INC.

Dr. David Battleman notified the Board on May 30, 2023 of his resignation as director.
Resignation effective June 17, 2023, and not due to any dispute or disagreement with the Company.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Battleman

Director

LIPO · LIPELLA PHARMACEUTICALS INC.

Effective: 2023-06-17
Filed: June 1, 2023, 7:59 PM ET

On May 30, 2023, Dr. David Battleman informed the board of directors, or the Board, of Lipella Pharmaceuticals Inc. (the “Company”) that he will resign from the Board, effective June 17, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Battleman resigned as Director at LIPELLA PHARMACEUTICALS INC..

Action: resigned
Role: Director

Exact text from the filing

On May 30, 2023, Dr. David Battleman informed the board of directors, or the Board, of Lipella Pharmaceuticals Inc. (the “Company”) that he will resign from the Board, effective June 17, 2023.

View on SEC.gov

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-23-000765

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.